| 000 | 01218 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517090340.0 | ||
| 264 | 0 | _c20160824 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-15-3043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHyman, David M | |
| 245 | 0 | 0 |
_aMeasuring Toxicity in Phase I Clinical Trials--Letter. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cApr 2016 |
||
| 300 |
_a1828 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aEaton, Anne | |
| 700 | 1 | _aIvy, S Percy | |
| 700 | 1 | _aSpriggs, David R | |
| 700 | 1 | _aIasonos, Alexia | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 22 _gno. 7 _gp. 1828 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-15-3043 _zAvailable from publisher's website |
| 999 |
_c25885636 _d25885636 |
||